2019年冠状病毒病大流行期间肺动脉高压的右心导管检查
Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.
作者信息
Qaiser Kanza N, Lane James E, Tonelli Adriano R
机构信息
Department of Internal Medicine, Cleveland Clinic, Cleveland, USA.
Medical Intensive Care, Nursing Institute, Cleveland Clinic, Cleveland, USA.
出版信息
Pulm Circ. 2020 Sep 16;10(3):2045894020948783. doi: 10.1177/2045894020948783. eCollection 2020 Jul-Sep.
Abstract
Right heart catheterization is an essential diagnostic modality in the evaluation of pulmonary hypertension. The coronavirus disease 2019 pandemic has resulted in deferral of elective procedures including right heart catheterization. The benefits of proceeding with right heart catheterization, such as further characterization of hemodynamic subtype and severity of pulmonary hypertension, initiation of targeted pulmonary arterial hypertension therapy, as well as further hemodynamic testing, need to be carefully balanced with the risk of potentially exposing both patients and health care personnel to coronavirus disease 2019 infection. This review article aims to provide best clinical practices for safely performing right heart catheterization in pulmonary hypertension patients during the coronavirus disease 2019 pandemic.
摘要
右心导管检查是评估肺动脉高压的重要诊断方法。2019冠状病毒病大流行导致包括右心导管检查在内的择期手术推迟。进行右心导管检查的益处，如进一步明确肺动脉高压的血流动力学亚型和严重程度、启动针对性的肺动脉高压治疗以及进一步的血流动力学检测，需要与患者和医护人员可能暴露于2019冠状病毒病感染的风险进行仔细权衡。这篇综述文章旨在提供在2019冠状病毒病大流行期间安全地为肺动脉高压患者进行右心导管检查的最佳临床实践。
相似文献
1
Right heart catheterization for pulmonary hypertension during the coronavirus disease 2019 pandemic.2019年冠状病毒病大流行期间肺动脉高压的右心导管检查
Pulm Circ. 2020 Sep 16;10(3):2045894020948783. doi: 10.1177/2045894020948783. eCollection 2020 Jul-Sep.
2
Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic.新型冠状病毒肺炎（COVID-19）大流行期间肺动脉高压患者的护理
Pulm Circ. 2020 Apr 29;10(2):2045894020920153. doi: 10.1177/2045894020920153. eCollection 2020 Apr-Jun.
3
Right ventricle performances with echocardiography and Tc myocardial perfusion imaging in pulmonary arterial hypertension patients.超声心动图与 Tc 心肌灌注显像评估肺动脉高压患者右心室功能。
Exp Biol Med (Maywood). 2018 May;243(9):754-761. doi: 10.1177/1535370218775321.
4
Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization.右心导管检查过程中激发试验的血液动力学反应。
Ann Am Thorac Soc. 2022 Dec;19(12):1977-1985. doi: 10.1513/AnnalsATS.202201-077OC.
5
Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment - predictors of procedure success and duration in pulmonary artery hypertension.在常规 CMR 环境下进行心血管磁共振引导的右心导管检查 - 肺动脉高压中预测程序成功率和持续时间的因素。
J Cardiovasc Magn Reson. 2019 Sep 9;21(1):57. doi: 10.1186/s12968-019-0569-9.
6
Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension.多中心队列研究中肺动脉高压患儿的心导管检查和血液动力学。
Ann Am Thorac Soc. 2022 Jun;19(6):1000-1012. doi: 10.1513/AnnalsATS.202108-998OC.
7
Hemodynamic profiles in a series of patients undergoing right heart catheterization. Experience in one center of Medellin, Colombia.对一系列接受右心导管检查的患者的血液动力学特征进行分析。哥伦比亚麦德林中心的经验。
Arch Cardiol Mex. 2022;92(1):53-59. doi: 10.24875/ACM.20000528.
8
Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.肺动脉高压治疗起始患者行右心导管检查的发生率：一项基于人群的研究。
J Heart Lung Transplant. 2017 Feb;36(2):220-226. doi: 10.1016/j.healun.2016.07.017. Epub 2016 Jul 27.
9
Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.右心导管术监测肺动脉高压患儿的血液动力学。
J Am Heart Assoc. 2023 Apr 4;12(7):e029085. doi: 10.1161/JAHA.122.029085. Epub 2023 Mar 28.
10
The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.连续右心导管检查在肺动脉高压危险分层和管理中的作用。
Expert Rev Cardiovasc Ther. 2022 Jul;20(7):543-547. doi: 10.1080/14779072.2022.2092095. Epub 2022 Jun 22.
引用本文的文献
1
Clinical characteristics, treatment patterns and healthcare resource utilisation for portopulmonary hypertension patients in the USA: a real-world study.美国门脉性肺动脉高压患者的临床特征、治疗模式及医疗资源利用情况：一项真实世界研究
BMJ Open. 2025 Jun 19;15(6):e089223. doi: 10.1136/bmjopen-2024-089223.
2
Pathway to care, treatment and disease burden of pulmonary arterial hypertension: a real-world survey of physicians and patients in Latin America.肺动脉高压的护理、治疗途径及疾病负担：拉丁美洲医生和患者的真实世界调查
BMJ Open. 2024 Dec 31;14(12):e087263. doi: 10.1136/bmjopen-2024-087263.
3
Effects of COVID-19 pandemic on the management of pulmonary hypertension.新型冠状病毒肺炎大流行对肺动脉高压管理的影响。
Respir Med. 2023 Jan;206:107061. doi: 10.1016/j.rmed.2022.107061. Epub 2022 Nov 26.
4
Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.在三级医疗中心评估计算机断层扫描上的肺动脉高压征象并与超声心动图进行相关性研究
Cureus. 2022 May 25;14(5):e25319. doi: 10.7759/cureus.25319. eCollection 2022 May.
5
Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.在 COVID-19 大流行和远程医疗革命时代的肺动脉高压患者的风险评估：最新综述。
J Heart Lung Transplant. 2021 Mar;40(3):172-182. doi: 10.1016/j.healun.2020.12.005. Epub 2020 Dec 19.
本文引用的文献
1
The course of COVID-19 in a 55-year-old patient diagnosed with severe idiopathic pulmonary arterial hypertension.一名55岁被诊断为重度特发性肺动脉高压患者的新冠肺炎病程。
Pulm Circ. 2020 Jul 28;10(3):2045894020936659. doi: 10.1177/2045894020936659. eCollection 2020 Jul-Sep.
2
In the eye of the storm: the right ventricle in COVID-19.风暴之眼：新型冠状病毒肺炎中的右心室
Pulm Circ. 2020 Jul 2;10(3):2045894020936660. doi: 10.1177/2045894020936660. eCollection 2020 Jul-Sep.
3
Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19.新冠肺炎患者右心室纵向应变的预后价值。
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299. doi: 10.1016/j.jcmg.2020.04.014. Epub 2020 Apr 28.
4
Author rebuttal to response regarding "Letter to the Editor regarding 'Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?'".作者对关于“致编辑的信：肺动脉高压患者感染重症 COVID-19 的风险是否较低？”的回复的反驳。
Pulm Circ. 2020 Jun 23;10(3):2045894020936663. doi: 10.1177/2045894020936663. eCollection 2020 Jul-Sep.
5
Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: An epidemiological analysis.无症状感染者佩戴口罩可预防 SARS-CoV-2 传播：一项流行病学分析。
Travel Med Infect Dis. 2020 Jul-Aug;36:101803. doi: 10.1016/j.tmaid.2020.101803. Epub 2020 Jun 24.
6
COVID-19 and the pulmonary vasculature.新型冠状病毒肺炎与肺血管系统
Pulm Circ. 2020 Jun 10;10(3):2045894020933088. doi: 10.1177/2045894020933088. eCollection 2020 Jul-Sep.
7
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.血管紧张素转化酶抑制剂或血管紧张素受体阻滞剂的使用与 COVID-19 诊断和死亡率的关系。
JAMA. 2020 Jul 14;324(2):168-177. doi: 10.1001/jama.2020.11301.
8
Novel insights on the pulmonary vascular consequences of COVID-19.新型冠状病毒肺炎对肺血管影响的新认识。
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L277-L288. doi: 10.1152/ajplung.00195.2020. Epub 2020 Jun 17.
9
Natural History of Asymptomatic SARS-CoV-2 Infection.无症状SARS-CoV-2感染的自然史。
N Engl J Med. 2020 Aug 27;383(9):885-886. doi: 10.1056/NEJMc2013020. Epub 2020 Jun 12.
10
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.物理隔离、口罩和眼部防护预防 SARS-CoV-2 和 COVID-19 的人际传播：系统评价和荟萃分析。
Lancet. 2020 Jun 27;395(10242):1973-1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1.
Zotero 插件